Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

Celalettin Ustun, Jennifer Le-Rademacher, Hai Lin Wang, Megan Othus, Zhuoxin Sun, Brittny Major, Mei Jie Zhang, Elizabeth Storrick, Jacqueline M. Lafky, Selina Chow, Krzysztof Mrózek, Eyal C. Attar, Such Nand, Clara D. Bloomfield, Larry D. Cripe, Martin S. Tallman, Frederick Appelbaum, Richard A. Larson, Guido Marcucci, Gail J. RobozGeoffrey L. Uy, Richard M. Stone, Aminah Jatoi, Thomas C. Shea, Marcos de Lima, James M. Foran, Brenda M. Sandmaier, Mark R. Litzow, Harry P. Erba, Arti Hurria, Daniel J. Weisdorf, Andrew S. Artz

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study'. Together they form a unique fingerprint.

Medicine & Life Sciences